Nasopharyngeal Carcinoma in Non-Endemic Area: Challenges, Advances, and Perspectives

Information

SCIENTIFIC RATIONALE
Nasopharyngeal Carcinoma (NPC) is a rare cancer in non-endemic settings. According to European Society of Medical Oncology (ESMO) guidelines, locally advanced disease is treated with combination of chemotherapy and radiotherapy. Recently, proton therapy has been introduced as a treatment option for nasopharyngeal carcinoma in light of its unique physical properties. However, late treatment sequelae still occur, and a small subset of patients experience disease relapse. In endemic setting, a new standard of care has been recently set with the introduction of immunotherapy in combination with platinum-based chemotherapy.
Almost all the evidence-based clinical indication in the management of this disease have been mutated from trials conducted in endemic areas. Therefore, there’s the urgent need to better refine the management of nasopharyngeal carcinoma in non-endemic setting.
This congress will provide the paramount opportunity to collect the expertise of internationally recognized physicians in the care of this disease and pave the way for knowledge building through the design of novel clinical trials conducted in non-endemic settings.

Chairperson

• Paolo Bossi Professor of Medical Oncology
  Humanitas University,
  Head of Head & Neck and
  Non-melanoma Skin Cancer Oncology Unit,
  Humanitas Research Hospital
• Marta Scorsetti Resp. dell’Unità Operativa di Radioterapia e Radiochirurgia, Humanitas Research Hospital | Direttore Scuola di Specializzazione di Radioterapia, Humanitas University
• Giuseppe Spriano Professor of Otolaryngology-Head & Neck Surgery,
  Humanitas University,
  Head of Department of Otolaryngology-Head & Neck Surgery,
  Humanitas Research Hospital

Contact

ORGANIZING SECRETARIAT
Humanitas EDU
edu@hunimed.eu

Registration

Registration to the event is free and can be made at this web page only.

Maximum number of attendees: 150

SPECIALTIES INVOLVED
Otholaryngologist and ENT surgeons, Medical Oncologist, Radiation Oncologist, Anatomopathologist, Molecular Biologists, Radiologist and Nuclear Medicine specialist.